Dementia feels inevitable. It’s a shadow that hangs over aging, waiting for you. But what if it isn’t?
In July, over 10,00 brain researchers packed into a conference in London. They were there to discuss strategies for beating cognitive decline. But the loudest cheers weren’t for a new drug. They were for Isabel Beltre.
Beltre isn’t a scientist. She’s a patient. Specifically, she was part of the LatAm-FINGERS trial, a massive study designed to test if lifestyle changes could actually prevent dementia before symptoms start.
Her transformation was real. Before the trial, she needed her grandson’s help with basic tasks. Now? She does everything herself. Her story wasn’t an anomaly. The trial results, released at that same conference, showed that tailored lifestyle interventions didn’t just help a few outliers. They significantly boosted thinking skills for the group as a whole.
The question now isn’t “if” it works, but “how” we can make it work for everyone.
How lifestyle interventions differ from medication
Most people think of Alzheimer’s treatment as pharmacological. You get a prescription; you hope the amyloid plaques dissolve. But the LatAm-FINGERS trial took a different path. Instead of treating the disease after it struck, it attacked the risk factors that pave the road to it.
These risks aren’t abstract. The Lancet Commission’s 2024 review identified 14 of them. Smoking. Social isolation. Lack of exercise. Poor hearing. Together, these factors contribute to 45% of all dementia cases at a population level. That is nearly half.
Dr. Miia Kivipelto, whose original FINGER study in Finland spawned this entire movement, realized early on that you can’t fix one piece in isolation. If you only treat the heart but ignore the mind, you fail. If you only focus on diet but miss social connection, you miss half the picture.
So, the LatAm-FINGERS study recruited 1,200 people aged 60 to 77. It didn’t give them pills. It gave them a overhaul.
Participants received personalized nutrition plans. Brain training sessions. Regular exercise programs. And crucially, social activities. This wasn’t a passive “eat your vegetables” lecture. It was an active, multi-part intervention lasting two years.
The result? Statistically significant improvements in thinking skills.
Why the Latin American approach succeeded where others struggled
If the original FINGER study in Finland showed a 25% improvement in brain function, why does the Latin American version get more hype?
It comes down to who is in the trial.
In the U.S. POINTER study, 70% of participants had college degrees. In Finland, they were fairly average. In Latin America? Only 63% had finished high school. The LatAm-FINGERS cohort was less educated, more representative of the general population, and carried a higher burden of modifiable risks like high BMI.
This is key for understanding how to prevent dementia in high-risk populations.
“In Latin America, there are more modifiable risks,” Dr. Kivipelto noted. “We reaped the rewards of delivering the intervention people needed most.”
Because the participants had more room for improvement, the study saw a 0.11 z-score difference between the test and control groups. That’s more than double the difference seen in the original Finnish trial (0.04 z-scores). In concrete terms, the test group showed a 55% relative improvement in overall brain function compared to those who received only basic health advice.
The flexibility was also part of the magic. Researchers didn’t force a generic plan on everyone. In Ecuador, they moved exercise classes out of hot gyms and into the shade during sweltering summers. In other regions, dietary advice reflected locally available produce rather than imported superfoods.
This tailored approach is what experts like Dr. Gill Livingston argue is the future of dementia prevention. One size does not fit all.
The gender gap in brain training
The results weren’t universal. That’s an important detail often lost in the celebration.
The study found a striking disparity: women benefited significantly. Men did not. Their cognitive abilities remained statistically similar to the control group.
Why? The data suggests engagement levels differed. Women participated in the exercise and social activities more consistently. As Dr. Livingston pointed out, traditional exercise classes and social brain-training modules may simply be less appealing to men.
It’s an uncomfortable truth. If we want to prevent dementia in half the population, we can’t design programs that only appeal to women. We need to ask why men disengage. Is it the time commitment? The social dynamic? The physical demand? The answers are messy, and the field is still figuring them out.
Can we actually stop dementia rates from rising?
Here’s the cold water: LatAm-FINGERS improved cognitive scores. It did not prove that dementia cases dropped.
Why? Because dementia takes years, sometimes decades, to manifest. A two-year study isn’t long enough to measure incidence rates. Only two previous trials have attempted to track actual dementia development, and neither saw a notable drop in cases. And those studies didn’t include cognitive training.
Implementing intensive, multi-component trials like LatAm-FINGERS on a national scale isn’t practical. You can’t put millions of elderly people through personalized nutrition and brain training sessions. The infrastructure simply isn’t there.
So, what’s the path forward?
Dr. Kivipelto is optimistic. She points to new blood-based tests for Alzheimer’s markers. These could provide a faster, cheaper way to measure if lifestyle changes are actually slowing biological aging in the brain. It’s an indirect measure, but it’s faster than waiting for dementia to strike.
For now, the message from experts is clear. We can’t eliminate every risk. Air pollution? You can’t just move to the country and breathe better. But you can control what you can. Smoking, diet, exercise, social connection.
These factors account for nearly half the risk.
Isabel Beltre doesn’t talk about z-scores or statistical significance. She talks about independence. She talks about doing things for herself again. That’s a victory.
Whether it’s enough to stem the tide of a global dementia epidemic remains uncertain. The science is promising. The biology is hopeful. But the logistics? The culture shifts needed for men to engage? The funding to scale it up? Those are the hard parts.
We know the levers. We just have to decide if we’re willing to pull them.
